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journal homepage: http: / /www.pediatr -neonatol .comLETTER TO THE EDITORUpdated Guidelines for Childhood Pneumonia
Management: A Promising Role for Lung
UltrasoundTo the Editor,
We are grateful to read the comments sent to the journal
regarding our article “Usefulness of Lung Ultrasound in the
Diagnosis of Community-acquired Pneumonia in Children”.1
These comments raised some important points regarding
the role of lung ultrasound (LUS) in childhood pneumonia
management in some recent publications. We agree with
these thoughtful comments and would like to further clarify
its updated and growing roles with special emphasis on
some current guidelines.
Accordingly, the British Thoracic Society (BTS) guide-
line for community-acquired pneumonia (CAP) in chil-
dren,2 one of the major references in managing pediatric
pneumonia recommends that the diagnosis of pneumonia
is based on clinical features such as fever, tachypnea,
breathlessness or difficulty in breathing, cough, wheezing,
or chest pain, with varied sensitivity. Similarly, another
guideline published by both the Infectious Diseases Soci-
ety of America (IDSA) and Pediatric Infectious Diseases
Society (PIDS),3 suggests that the diagnosis of pneumonia
should only be based on clinical presentations. LUS or
computed tomography (CT) could supply more detailed
information for complicated para-pneumonic effusion by
multi-plane assessment only when a chest X-ray (CXR) is
not conclusive. As for the resource-poor regions of the
world, the guidelines set by World Health Organization,4
defines pneumonia primarily as a cough and/or difficult
breathing, with or without fever, fast breathing, or lower
chest wall in-drawing. All three major guidelines recom-
mend that the diagnosis of pneumonia is based on clinical
presentations, and CXR or LUS should not be taken
routinely.
However, there is growing evidence suggesting the role
of LUS in a variety of pulmonary diseases, mostly focused
on the diagnosis of CAP.5e7 These studies weighted the
benefit of LUS in CAP because of its high sensitive andhttp://dx.doi.org/10.1016/j.pedneo.2015.03.005
1875-9572/Copyright ª 2015, Taiwan Pediatric Association. Published bspecificity for diagnosing CAP, without causing harm to the
patient.5,7 Therefore, many believe that LUS is a safer and
more convenient imaging modality than CXR and CT,
owing to the lack of radiation and its feasibility on the
bedside. In line with these studies, our results suggest
that, except in certain patients limited by bone tissue and
air filled structures, with well-trained techniques LUS is a
comparable imaging tool with CXR, and it can be used as a
primary diagnostic modality in many pediatric chest
diseases.
To date, LUS is not regarded as the standard modality for
the diagnosis of pneumonia but has an essential and dedi-
cated role in managing complicated pneumonia. BTS
guidelines for pneumonia in childhood suggest that effu-
sions are found in as many as 40% of hospitalized children
with CAP, and the amount of fluid is best estimated by LUS.2
In addition, in the presence of abscess or empyema, a
bedside LUS can be used to guide percutaneous drainage
when patients are too critical to be transferred to the CT
room.2 Furthermore, IDSA/PIDS guidelines even suggest
LUS-guided percutaneous needle aspiration for direct cul-
ture of pathogens while sputum culture is difficult or
negative.3 Finally, if there is a doubt of pleural fluid versus
parenchymal opacification on CXR, further imaging with
LUS or CT scan is warranted.3 Taken together, we believe
that LUS can not replace CXR in the diagnosis of simple
pneumonia as shown in current guidelines. However, its
role in providing essential information to confirm and
manage complicated pneumonia in children, as compared
with CXR or CT, should be addressed in future studies or
guidelines.
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